L

LianBio

Biotech & Life Sciences · Pudong, China · Founded 2019 · IPO 2021

LianBio operates at the intersection of global biotech innovation and the expansive healthcare market in China and major Asian regions. The company focuses on identifying and sourcing top-tier therapeutic opportunities and creating new treatment paradigms for first-in-class programs. LianBio's unique business model is designed to support leading biotech companies that have not previously engaged in development within China and other major Asian markets. By leveraging a global innovation mining platform and a China-centric execution strategy, LianBio facilitates access to these large and dynamic healthcare landscapes, enhancing global development initiatives for its partners. LianBio serves biotech companies looking to expand their reach into the Asian healthcare market. The company operates in the healthcare and biotechnology sectors, focusing on unmet medical needs and innovative treatment approaches. Its business model revolves around strategic and financial partnerships, enabling it to bring advanced medical science to patients in need. Revenue is generated through these partnerships, which often involve collaborative development and commercialization agreements. Keywords: biotech, healthcare, innovation, China, Asia, partnerships, therapeutic, development, medical, science.